Journal Review Series: July-September 2018
Derm In-Review Advisory Council Member, Dr. Ramya Kollipara, searched the journals so that you don’t have to! She reports on important take-aways from different dermatology journals for the months of July, August, and September of 2018.
It is key to keep in mind that “important” is subjective and what is contained in this review is one person’s view of what should be remembered from the …
Derm In-Review Advisory Council Member, Dr. Ramya Kollipara, searched the journals so that you don’t have to! She reports on important take-aways from different dermatology journals for the months of July, August, and September of 2018.
It is key to keep in mind that “important” is subjective and what is contained in this review is one person’s view of what should be remembered from the … Continue reading "Journal Review Series: July-September 2018"
In a 20-minute lecture presented at the 16th Annual ODAC conference, Dr. Patel reviewed the appropriate management of actinic keratoses and squamous cell carcinoma. Grabbing the attention of the audience early on, Dr. Patel quoted the staggering statistics for squamous cell carcinoma – calling the growing epidemic “a public health crisis.” He challenged dermatologists to lead the charge in … 
Next Steps readers had the opportunity to ask Dr. Vishal Patel questions on managing advanced cutaneous malignancy, high-risk skin cancers in immunocompromised patients, and the importance of certification in Mohs Surgery. See all of his insightful answers below.
What leadership positions are available for dermatology residents interested in pursuing a Mohs fellowship?
There are a variety of … 
We are excited to announce our Next Steps mentor for the month of February: Dr. Vishal Patel. In this monthly Ask a Mentor segment, we identify an accomplished mentor in the field of Dermatology to answer your questions about career development and their unique areas of expertise.
If you have questions about advanced cutaneous malignancy management, specifically high-risk squamous cell carcinom …